$10.490
+0.131 (+1.25%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
OCUL Prediction & Forecast by Similar Chart Analysis
Alphio's OCUL stock price prediction model matches the current Ocular Therapeutix Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.85 (+2.65%). The 1-week path is $10.77 (+1.91%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Ocular Therapeutix Inc Stock?
Ocular Therapeutix Inc (OCUL) appears to be a good buy right now due to its recent positive trial results and bullish analyst ratings. The stock is currently priced at $10.36, with analysts setting price targets as high as $30, suggesting a potential upside of over 189%. Additionally, the RSI is at 41.34, indicating that the stock is not overbought, and the recent surge in market sentiment following EyePoint's trial failure strengthens OCUL's competitive position. However, the company has reported substantial net losses, with a net income of -78.76 million in Q2 2026, which remains a significant risk to consider.
OCUL stock price ended at $10.49 on Monday, after rising +1.25%
Ocular Therapeutix Inc (OCUL) last closed at $10.57, gaining +0.76%. These facts feed the 1-day and 1-week OCUL price prediction above.
Analyst Consensus
Ocular Therapeutix Inc (OCUL): 5 buy, 2 hold, 0 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Ocular Therapeutix Inc (OCUL) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches OCUL, ranked by similarity.
Seasonality analysis for OCUL
Historically the probability of a positive September return for OCUL is 97.62%. October offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for OCUL
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Sep 2026 | $5.63 | $7.17 | $8.37 | -32.17% |
| Oct 2026 | $5.81 | $6.65 | $8.63 | -37.04% |
| Nov 2026 | $4.79 | $6.56 | $7.88 | -37.95% |
| Dec 2026 | $4.99 | $6.65 | $8.20 | -37.04% |
In 2026, Ocular Therapeutix Inc (OCUL) is projected to range from $4.79 to $8.63.
Ocular Therapeutix Inc 2026 monthly forecast
In Sep 2026, Ocular Therapeutix Inc is projected to average $7.17, with a low of $5.63 and high of $8.37.
In Oct 2026, Ocular Therapeutix Inc is projected to average $6.65, with a low of $5.81 and high of $8.63.
In Nov 2026, Ocular Therapeutix Inc is projected to average $6.56, with a low of $4.79 and high of $7.88.
In Dec 2026, Ocular Therapeutix Inc is projected to average $6.65, with a low of $4.99 and high of $8.20.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.